Bleakley Financial Group’s ADMA Biologics ADMA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-66,354	Closed	-$1.21M	–	761
2025 Q4	$1.21M	Buy	66,354 +52,562	+381%	+$886K	0.02%	438
2025 Q3	$202K	Buy	+13,792	New	+$236K	﹤0.01%	585
2025 Q2	–	Sell	-10,697	Closed	-$212K	–	571
2025 Q1	$212K	Sell	10,697 -6,042	-36%	-$104K	0.01%	502
2024 Q4	$287K	Buy	16,739 +6,498	+63%	+$122K	0.01%	812
2024 Q3	$205K	Buy	10,241 +37	+0.4%	+$575	0.01%	920
2024 Q2	$114K	Sell	10,204 -151	-1%	-$1.27K	﹤0.01%	947
2024 Q1	$68.3K	Hold	10,355	–	–	﹤0.01%	953
2023 Q4	$46.8K	Sell	10,355 -103	-1%	-$381	﹤0.01%	926
2023 Q3	$37.4K	Sell	10,458 -564	-5%	-$2.17K	﹤0.01%	859
2023 Q2	$40.7K	Sell	11,022 -340	-3%	-$1.26K	﹤0.01%	904
2023 Q1	$37.6K	Buy	+11,362	New	+$39.3K	﹤0.01%	884